|
HS Code |
509618 |
As an accredited 6-Bromo-4-Aza-2-Oxindole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Aza-2-Oxindole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sometimes, scientific inquiry calls for something out of the ordinary, a compound that doesn’t just sit quietly in the background, but instead opens up possibilities. 6-Bromo-4-aza-2-oxindole is one of those rare intermediates that tends to catch the attention of medicinal chemists, synthetic organic researchers, and anyone exploring new molecular frameworks. Across years of experience in academic and industrial labs, I’ve watched certain chemical families gain cult followings for the flexibility they offer. What sets this compound apart isn’t just its molecular structure, but how that structure invites creative pathways, thanks to the presence of both a bromine substituent and an aza-heterocycle within the oxindole scaffold.
A well-placed halogen atom, in this case bromine, is more than an ornamental detail on a molecule. Bromine at the 6-position serves as a springboard for selective chemical modifications. I’ve seen brominated intermediates form the backbone of exploratory syntheses, especially in pharmaceutical lead discovery, where the ability to make small changes efficiently can reveal major differences in biological activity. In 6-bromo-4-aza-2-oxindole, that bromine secures a firm anchor for cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings. These reactions have become mainstays in modern organic chemistry for linking fragments together under mild conditions, expanding a chemist’s reach into previously inaccessible structures. Adding in a nitrogen at the 4-position, the aza group doesn’t just change the electron distribution; it creates new pharmacophoric potential and alters how the molecule interacts with protein targets. I’ve swapped unsubstituted indoles for their aza cousins before, and the difference in reactivity and binding profiles can be surprising.
In any research laboratory, consistent quality in starting materials makes all the difference. 6-Bromo-4-aza-2-oxindole typically arrives as a pale solid, and while its molecular formula may seem simple, ensuring high purity demands solid technique and strict quality assurance. Usually, it’s sold in gram to multi-gram batches with stated purity above 98 percent by HPLC or NMR validation. Nobody in the lab wants mystery peaks showing up in chromatographic runs, so researchers expect precise analytical documentation before the bottle hits the bench. Every time I’ve ordered oxindole derivatives, I look for transparent batch records and independently confirmed NMR spectra. Some producers now offer options for custom scales, and that flexibility matters to both discovery teams and process chemists scaling up for further development.
The molecular weight hovers around the 225 g/mol mark, making it manageable for weighing, handling, and dissolving in a range of organic solvents. In my own hands, it dissolves well in DMSO and N,N-dimethylformamide, but you can also coax it into acetone or methanol with a little warming. Its melting point, usually reported near 145-150 degrees Celsius, indicates a stable, crystalline nature, and I’ve found it surprisingly forgiving when it comes to storage. Under standard dry-box conditions, with protection from excess humidity and light, I’ve kept open samples for months without any detectable degradation. This resilience eliminates headaches caused by unstable intermediates, which can disrupt carefully planned research timelines.
Over the years, I’ve noticed that researchers gravitate toward 6-bromo-4-aza-2-oxindole when exploring new kinase inhibitor scaffolds, building blocks for peptidomimetic analogs, and small-molecule probes of enzyme function. This compound manages to straddle the line between versatile and specialized. The bromine atom transforms it from a structural mimic into a true synthetic workhorse; it becomes an inviting handle for aryl, heteroaryl, or alkylation. As a result, dozens of analogs can be generated in a single campaign, each with slight structural twists that reveal key structure-activity relationships. That’s a big deal for medicinal chemistry, where a single atom swap can mean the difference between potent inhibition and bland inactivity.
Beyond medicinal chemistry, I’ve seen 6-bromo-4-aza-2-oxindole play a role in academic syntheses targeting more complex natural products. The aza-indole motif appears in the core structures of diverse bioactive alkaloids. Through cross-coupling and cyclization strategies, I’ve been part of teams that successfully expanded core rings, installed functionalized side chains, and created libraries for biological testing. In some synthetic routes, it supplies a nitrogen atom just where it’s needed for a regioselective ring closure, enabling the stepwise assembly of heterocyclic targets. That sort of adaptability—balancing robust reactivity with sound selectivity—earns it a perennial spot on research benches.
I remember one grant-funded project where our group chased a new set of central nervous system agents inspired by a hybrid approach to classical scaffolds. Having a reliable source of 6-bromo-4-aza-2-oxindole let us run parallel reactions, test new ligands, and, ultimately, discover lead compounds with improved brain permeability. Product consistency and predictable reactivity saved weeks of troubleshooting, reinforcing how valuable high-standard batches are to fast-paced research environments.
An endless parade of intermediates comes across the synthetic chemist’s bench, so what makes this one stand out? The main edge lies in the combined presence of bromine and the aza group within the oxindole core. Some might reach for plain 6-bromoindole or 6-bromooxindole when building polycyclic targets, but adding the aza brings a different reactivity palette, especially in terms of nucleophilicity, hydrogen bonding, and overall electronic character. Over the years, I’ve run side-by-side assays comparing aza and non-aza analogs, and the subtle differences can push a stalled synthesis into completion or open new biological hit windows.
In practical terms, 6-bromo-4-aza-2-oxindole often replaces less selective arylbromides. Standard bromooxindoles sometimes lack the unique hydrogen bond acceptor ability enabled by the aza nitrogen. In modern medicinal chemistry campaigns, where fragment-based screening is now routine, the added nitrogen supports exploration of polar interactions and increases hit rates in target-focused libraries. One of the best features of this compound is its straightforward compatibility with standard laboratory techniques. I’ve run cross-couplings in glassware no more exotic than a basic Schlenk line; it doesn’t demand unusual precautions, other than the usual hood work and proper solvent choices given its modest volatility.
I’ve spoken to senior colleagues who recall working with similar indole compounds decades ago; in many cases, the lack of a bromine substituent or aza-nitrogen left the resulting analogs either too inert or too prone to side reactions. Adding those functionalities delivers control. The molecule takes well to further functionalization, and I’ve seen it produce better yields and cleaner profiles compared with other bromoindole building blocks, especially in carbocycle construction or biaryl assembly. Researchers interested in exploring drug discovery or even developing specialized agrochemicals often reflect on how certain intermediates simplify or even unlock entire routes that would stall with a less cooperative scaffold.
Having worked in places where budget considerations and supply chain hiccups can disrupt projects, I’ve grown impatient with products that overpromise but underdeliver, usually due to poor analytical follow-through or questionable handling. The oxindole family, and this analog especially, stands out because trustworthy vendors provide detailed certificates of analysis, complete NMR assignments, and actual batch information. I remember sending a batch of 6-bromo-4-aza-2-oxindole out for independent purity testing; the results matched the vendor claims, which isn’t always the case with other, less familiar intermediates. That level of transparency reduces uncertainty and builds trust across research teams, something that often goes overlooked until things go wrong.
Real-world research isn’t just about hitting purity thresholds. Shelf stability matters, especially for compounds that see repeated use over several weeks or months. In my experience, this material holds up well—no unexpected decomposition, no subtle color changes or new peaks creeping into the baseline. It makes planning multistep syntheses easier, since researchers can count on the starting material behaving the same way day after day. The predictability of its reactions has played a role in enabling fast structure-activity relationship work and has kept screening libraries clean and comparable. This reliability translates directly into cost savings and more robust science.
With the surge in interest in small-molecule therapeutics, the demand for flexible and modifiable building blocks has spiked. The pharmaceutical industry, universities, and even biotech startups now look for chemicals that support diverse approaches, from classic organic methods to fragment-based drug design and even green chemistry. 6-Bromo-4-aza-2-oxindole has found its way into these workflows, not just as a bystander, but as an enabling intermediate. Its ability to play a starring role in cross-coupling or serve as a pivot point for ring expansions and cyclizations has been shown in dozens of published syntheses and patent filings.
Researchers need intermediates that support safe, scalable processes. The physical profile of 6-bromo-4-aza-2-oxindole, with its relatively high melting point and manageable solubility, supports routine handling in standard organic synthesis labs. I’ve been able to run milligram-scale screens for hit generation, then scale up successful routes to multi-gram quantities without materially changing reaction conditions or purification strategies. Its low toxicity profile, compared with some other halogenated heterocycles, made it suitable for undergraduate projects under supervision, which helped train new chemists without undue risk.
One detail that’s sometimes overlooked is sustainability. Many advanced intermediates suffer from supply bottlenecks due to cumbersome synthetic steps, dangerous reagents, or a reliance on rare starting materials. 6-Bromo-4-aza-2-oxindole avoids some of those pitfalls. The synthetic route to this compound generally starts with more common oxindole precursors and uses established bromination and aza-derivatization chemistry, which keeps costs in line and minimizes hazardous waste. In a market shifting toward more environmentally conscious chemistry, every step that can be achieved under mild conditions with fewer hazardous byproducts counts as a net benefit. In my own lab, we’ve managed to minimize the environmental impact of our syntheses by swapping out older aryl halides for more thoroughly studied alternatives like this compound.
Researchers still face persistent issues in medicinal chemistry, such as unpredictable reactivity, low yields, or toxic side products. Working with specialized scaffolds like 6-bromo-4-aza-2-oxindole offers a few practical solutions. Its compatibility with widely used cross-coupling protocols takes away much of the guesswork that stalls many projects. On top of that, I’ve found that its consistent performance lets teams focus on exploring new reactions or binding activities rather than tracking down obscure side products.
In practice, accessing new chemical matter efficiently means finding intermediates that don’t force chemists to compromise on purity, scalability, or safety. With this oxindole derivative, I’ve run reactions that produced clean, easily purified products in both research and teaching settings. Simple filtration, basic column chromatography, and routine crystallization techniques suffice. If challenges do crop up—say low reactivity or minor solubility issues—tweaking solvents or bases often solves the problem. As a result, troubleshooting stays manageable, even for less experienced team members.
Long-term project success depends on access to reliable data. Vendors supplying quality 6-bromo-4-aza-2-oxindole typically share comprehensive analyses, up-to-date safety details, and documentation showing compliance with regulatory guidelines where relevant. Having those resources in hand helps research groups satisfy internal review boards and facilitates smoother patent filings. Overly complex or poorly characterized intermediates, by contrast, can bring valid projects to a grinding halt. The increased transparency around this product has helped set a new standard for intermediates in its class.
As interest in new pharmacophores grows, so does the need for robust, modifiable intermediates. The role of 6-bromo-4-aza-2-oxindole in supporting both high-throughput screening and more targeted syntheses positions it well for the changing demands of chemical research. In the last few years, I’ve seen a shift toward designing “privileged” scaffolds that can be varied at multiple positions in a single synthetic operation. This compound has all the hallmarks of an ideal foundation: easily accessed, structurally tunable, and compatible with standard resources found in most academic and industry labs.
For startups and research teams working on a shoestring, resourcefulness makes all the difference. I’ve mentored students who managed to turn out publishable results using nothing more than shaking flasks and modest reagent lists, made possible by picking user-friendly scaffolds. The brominated, aza-substituted oxindole represents a sweet spot—not exotic enough to blow the budget, but sophisticated enough to unlock grant-winning molecular libraries. Veteran chemists appreciate how it saves days of troubleshooting and sidesteps the capricious nature of less well-tested intermediates.
Advancing new therapeutics and materials increasingly depends on chemicals like 6-bromo-4-aza-2-oxindole, which let projects move from concept to prototype with fewer hurdles. Expanded supplier transparency, clear batch records, and peer-reviewed data foster trust and encourage more widespread, responsible use of these intermediates. In my view, the community would benefit from a few changes: more vendor collaboration on quality benchmarks, easier access to real-time analytical data, and broader dissemination of reaction protocols. These steps would help both newcomers and seasoned researchers build upon successful labs rather than repeat old mistakes.
As researchers, we’re often at the mercy of suppliers for product consistency and reliability. When vendors communicate openly, supplying not only a bottle but a robust data trail, everyone wins. On another front, simplifying compliance with global regulatory requirements could prevent unnecessary slowdowns. While this product isn’t currently heavily regulated due to its modest hazard profile, future-proofing processes with complete safety and environmental details can prevent headaches for multinational teams.
From hands-on experience across several institutions, intermediates like 6-bromo-4-aza-2-oxindole aren’t mere reactants; they’re vehicles for discovery. Choosing reliable, versatile building blocks shapes the pace and direction of scientific advancement. This compound’s combination of manageability, reactivity, and thoughtful supplier documentation has helped me and many others go further, faster. Every time a project transitions smoothly from ideas on the page to robust chemical reality with support from this material, it’s a quiet reminder that good science still depends on smart choices at the bench. As research horizons broaden and demands grow, a dependable scaffold like this one often ends up being the unsung hero behind the next breakthrough.